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        Introduction 
  Nuclear factor     B  (NF-    B) is a ubiquitously expressed tran-
scription factor and, in mammals, consists of fi  ve family mem-
bers: RelA/p65, c-Rel, RelB, p50 (the processed form of p105), 
and p52 (the processed form of p100;   Hayden and Ghosh, 
2004  ). These subunits contain a DNA-binding protein dimer-
ization domain and nuclear localization signal, but only RelA/
p65 (hereafter referred to as p65), c-Rel, and RelB possess 
transactivation domains (TAs). NF-     B forms homo- and het-
erodimers, with the p50  –  p65 complex being the most common. 
In most cells, NF-     B is bound to I     B inhibitor proteins that mask 
its nuclear signal and sequester it in the cytoplasm (  Huxford 
et al., 1998  ). 
 NF-    B is regulated by a variety of factors, such as infl  am-
matory cytokines that direct NF-     B by what is now referred to 
as the classical pathway (  Ghosh and Karin, 2002  ). This occurs 
through stimulation of the inhibitor of      B kinase (IKK) com-
plex consisting of two catalytic subunits, IKK      and  IKK   ,  and 
a regulatory subunit, IKK    /NF-    B essential modulator/IKKAP1 
( Karin,  1999 ).  Once  activated,  IKK     phosphorylates I    B  pro-
teins, targeting them for ubiquitination and proteasomal degra-
dation. This releases p50 – p65 or p50 – c-Rel dimers to translocate 
to the nucleus and bind DNA, where they induce gene expres-
sion. Mice null for IKK    ,  IKK    , or p65 are embryonic lethal as 
a result of massive liver apoptosis, and cells derived from these 
embryos are unresponsive to classical NF-   B inducers ( Beg et al., 
1995b  ;   Tanaka et al., 1999; Rudolph et al., 2000  ), demonstrat-
ing a signaling link between p65, IKK     , and IKK      subunits. 
  In response to a second set of factors that include CD40L, 
B cell  –  activating factor, and lymphotoxin     ,  NF-   B  is  activated 
through an alternative pathway independent of IKK      ( Pomerantz 
and Baltimore, 2002  ). Instead, activation proceeds through the 
  N
uclear factor      B (NF-     B) is involved in multiple 
skeletal muscle disorders, but how it functions in 
differentiation remains elusive given that both 
anti- and promyogenic activities have been described. 
In this study, we resolve this by showing that myogenesis 
is controlled by opposing NF-     B signaling pathways. 
We ﬁ nd that myogenesis is enhanced in MyoD-expressing 
ﬁ   broblasts deﬁ   cient in classical pathway components 
RelA/p65, inhibitor of      B kinase       (IKK     ), or IKK     . 
Similar increases occur in myoblasts lacking RelA/p65 
or IKK     , and muscles from RelA/p65 or IKK      mutant 
mice also contain higher ﬁ  ber numbers. Moreover, we 
show that during differentiation, classical NF-     B signal-
ing decreases, whereas the induction of alternative 
members IKK     , RelB, and p52 occurs late in myogenesis. 
Myotube formation does not require alternative signal-
ing, but it is important for myotube maintenance in re-
sponse to metabolic stress. Furthermore, overexpression 
or knockdown of IKK      regulates mitochondrial content 
and function, suggesting that alternative signaling stim-
ulates mitochondrial biogenesis. Together, these data 
reveal a unique IKK/NF-     B signaling switch that func-
tions to both inhibit differentiation and promote myo-
tube homeostasis.
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was also determined that p38 MAPK-induced myogenesis func-
tions through IL-6 synthesis in an NF-    B – dependent  manner 
(  Baeza-Raja and Munoz-Canoves, 2004  ). 
  Collectively, these studies show that NF-     B function in 
skeletal muscle differentiation remains at best enigmatic. Resolving 
this will not only provide insight into the involvement of NF-    B 
during muscle development and repair but may also increase our 
understanding of its participation in a growing list of muscle-
wasting disorders, including cachexia (  Guttridge et al., 2000  ; 
  Cai et al., 2004  ;   Mourkioti et al., 2006  ), disuse atrophy (  Hunter 
and Kandarian, 2004  ), muscular dystrophies (  Baghdiguian et al., 
1999  ;   Kumar and Boriek, 2003; Acharyya et al., 2007 ),  and  in-
fl  ammatory myopathies (  Monici et al., 2003  ). To this end, we 
used a genetic approach to decipher the role of NF-    B/IKK  sub-
units during myogenic differentiation. Our results   provide an 
explanation for the previously reported anti- and promyogenic 
activities of NF-     B by revealing that myogenesis involves both 
classical and alternative NF-    B  pathways. Although  constitutive 
activation of the classical pathway functions in myoblasts to in-
hibit differentiation, NF-     B signaling switches to the alternative 
pathway late in the myogenic program to promote mitochondrial 
biogenesis and myotube homeostasis. 
  Results 
  Myogenic activity is enhanced in p65 
    /       
MEFs expressing MyoD 
  To extend our understanding of NF-     B in skeletal myogenesis, 
we used established mouse embryonic fi  broblasts (MEFs) that 
were wild type or null for individual NF-    B  subunits  converted 
to skeletal muscle by exogenous expression of MyoD (  Davis 
et al., 1987  ). We initiated this analysis with p65 because this sub-
unit is constitutively active in myoblast nuclei (  Guttridge et al., 
1999  ). Results showed that myogenic activity derived from a 
troponin (Tn) I enhancer reporter plasmid (TnI-luc) was signifi  -
cantly enhanced in   p65 
   /       MEFs compared with wild-type cells 
( Fig.  1  A ).  Similar  fi  ndings were obtained with plasmids con-
taining the acetylcholine receptor promoter (AchR-luc) or mul-
timerized muscle regulatory factor binding sites (4RTK-luc), 
arguing that this effect was not reporter specifi  c. To verify the 
specifi  city of p65 regulation, reporter assays were repeated in 
early passaged primary fi  broblasts prepared from embryonic 
day (E) 13.5   p65 
+/+   ,   p65 
+/       , and   p65 
   /       embryos. Myogenic ac-
tivity was again elevated in MEFs lacking p65, which occurred 
in a gene dosage  –  dependent manner (  Fig. 1 B  ). This confi  rmed 
that p65 regulation of myogenesis was not a consequence of cell 
immortalization. As a control, myogenesis was also assessed in 
primary MEFs that were wild type or null for the retinoblas-
toma (Rb) protein, a cell cycle checkpoint required for skeletal 
muscle differentiation ( Novitch et al., 1999 ). As predicted, reporter 
activity was signifi  cantly impaired in   Rb 
   /       MEFs (  Fig. 1 B  ), 
thus supporting the relevance of our fi  ndings with p65. To fur-
ther address p65 specifi  city, myogenic assays were extended 
to MEFs lacking other NF-     B subunits. Results showed that 
  activity from   cRel 
   /       or   p50 
   /       MEFs was considerably lower 
than that for   p65 
   /       cells (  Fig. 1 C  ). In addition, we used MEFs 
defi  cient in I    B     that contain constitutive levels of nuclear p65 
NF-     B  –  inducing kinase (NIK) that phosphorylates and activates 
IKK      homodimers and, in turn, phosphorylates p100 in com-
plex with RelB. This leads to ubiquitin-dependent processing 
of p100 to p52 and translocation of p52  –  RelB to the nucleus 
(  Senftleben et al., 2001  ;   Xiao et al., 2001  ). B cell  –  activating 
factor, NIK, and p100  –  p52 knockout mice have similar pheno-
types (  Gerondakis et al., 1999  ), confi  rming that these molecules 
are also part of the same linear nonclassical signaling cascade. 
In addition, the classical and alternative pathways are thought to 
regulate distinct genes in response to their various activators 
(  Dejardin et al., 2002; Bonizzi et al., 2004  ). 
  Aside from its more commonly accepted role as a regu-
lator of innate immunity and cell survival, NF-    B  is  also 
prominent in regulating cellular differentiation. In hematopoi-
etic cells, c-Rel and RelB are essential for B cell lymphopoie-
sis and T cell maturation (  Weih et al., 1996; Gerondakis et al., 
1999 ).  NF-    B is also required for osteoclastogenesis, and 
mice lacking p50 and p52 display severe osteopetrosis ( Iotsova 
et al., 1997  ). Furthermore, IKK      is important for skin differ-
entiation as well as skeletal and craniofacial morphogenesis 
(  Takeda et al., 1999; Hu et al., 2001  ;   Sil et al., 2004  ), a func-
tion thought to be independent of its kinase activity. 
  Over the past years, an increasing number of studies have 
also implicated NF-     B in skeletal muscle differentiation, a pro-
cess regulated by transcription factors MyoD, Myf5, myogenin, 
MRF4/Myf6/herculin, and MEF2A-D (  Naya and Olson, 1999  ; 
  Sabourin and Rudnicki, 2000; Pownall et al., 2002  ). These fac-
tors regulate myoblasts to undergo growth arrest and fuse into 
multinucleated myotubes. However, in contrast to hematopoiesis, 
the function of NF-     B in myogenesis is less defi  ned, and results 
have confl  icted as to whether NF-     B promotes or inhibits this 
differentiation process. On the one hand, studies demonstrate that 
NF-     B DNA binding and transcriptional activities decrease dur-
ing differentiation (  Lehtinen et al., 1996; Guttridge et al., 1999  ) 
and that inhibition of NF-     B via expression of the I    B     super-
repressor (SR) mutant accelerates myogenesis (  Guttridge et al., 
1999  ). In addition, activators of NF-     B such as TNF    ,  IL-1   ,  or 
the receptor-interacting protein (RIP) homologue RIP2 act as po-
tent inhibitors of differentiation (  Guttridge et al., 2000  ;   Langen 
et al., 2001  ;   Munz et al., 2002  ), which together support the notion 
that NF-     B functions as an inhibitor of myogenesis. NF-    B  me-
diates this regulation through the induction of cyclin D1 ( Guttridge 
et al., 1999  ) or by suppressing MyoD synthesis through a de-
stabilization element in the MyoD transcript ( Guttridge et al., 2000 ; 
  Sitcheran et al., 2003  ). More recent data suggest that NF-    B  can 
also inhibit myogenesis by stimulating expression of the Poly-
comb group protein YY1 (  Wang et al., 2007  ). 
  In contrast, similarly performed studies have reported that 
NF-     B activity increases during myogenesis in response to 
  insulin-like growth factor (  Kaliman et al., 1999; Conejo et al., 
2002  ). Insulin-like growth factor activation is mediated, in part, 
through the classical pathway, causing I    B     degradation  and 
p65 nuclear translocation, although the alternative pathway also 
appears to be involved because the overexpression of IKK      or 
NIK was seen to enhance myogenesis (  Canicio et al., 2001  ). 
In addition, the expression of I    B    -SR in L6 rat myoblasts was 
found to inhibit terminal differentiation markers, and recently it 789  IKK/NF-     B SIGNALING SWITCH IN SKELETAL MYOGENESIS   •   BAKKAR ET AL.
p65 (1  –  551) or TA mutant (1  –  521) strongly repressed myogen-
esis, whereas the expression of mutant (1  –  313) was effective in 
partially rescuing this regulation (  Fig. 2 D  ). To verify these 
  results, MyoD was stably expressed in   p65 
   /       MEFs along 
with wild-type or mutant forms of p65 (  Fig. 2 E  ). Consistent 
with reporter assays, myotubes were completely absent in 
  p65 
   /       MEFs expressing wild-type p65, whereas some myotubes 
formed in cells reconstituted with the (1  –  313) mutant (  Fig. 2 F  ). 
This suggested that residues within TA (521  –  551) are largely 
dispensable for repressing myogenesis, whereas residues 
(313  –  521) play a more signifi  cant role in this regulation. 
However, because the (1  –  313) mutant only partially rescued 
myogenesis, it further suggested that residues within the Rel 
domain contributed to p65-suppressive activity. Because the 
phosphorylation of serine 276 is required for p65 transactiva-
tion (  Zhong et al., 1998  ), we examined the involvement of this 
residue in regulating myogenesis. Reconstitution of   p65 
   /      
cells with p65 containing a 276 serine to alanine mutation was 
less effective in inhibiting myogenic activity, whereas muta-
tions outside the Rel domain in residues 529 and 536 had no 
effect (  Fig. 2 G  ). This is consistent with the aforementioned 
data showing that the deletion of TA (521  –  551) is not required 
for this regulation. In addition, the generation of serine to ala-
nine 276 in the p65 (1  –  313) mutant caused a full rescue of 
myogenic activity (  Fig. 2 H  ), demonstrating that NF-    B  regu-
lation of myogenesis is dependent on p65 transcriptional activ-
ity mediated from both serine 276 and other residues lying 
within the 313  –  521 domain. 
(  Beg et al., 1995a  ). Electrophoretic mobility shift assay con-
fi  rmed that NF-     B binding was higher in   I   B   
   /       MEFs,  which 
correlated with lower myogenic activity (  Fig. 1 D  ). Together, 
these genetic data indicated that p65 functions as a negative 
regulator of MyoD-induced myogenesis. 
  MEFs null for p65 are accelerated in their 
myogenic program 
  To examine how the absence of p65 exerts its effects on the 
myogenic program, MyoD was stably expressed in   p65 
+/+     and 
  p65 
   /       MEFs using a murine stem cell virus (MSCV)  –  MyoD-
IRES-GFP retrovirus. After selection, cells were sorted by fl  ow 
cytometry for GFP to ensure equal levels of MyoD (  Fig. 2 A  ). 
Cells were then differentiated, and myogenic markers were ana-
lyzed over a 4-d period. This analysis revealed that both the 
  induction and overall expression of markers muscle creatine 
  kinase, Tn, myosin heavy chain (MyHC), and tropomyosin 
were greater in cells lacking p65 (  Fig. 2 B  ). Myotube formation 
was also strikingly higher in   p65 
   /       cells (  Fig. 2 C  ), which 
  together supported the aforementioned reporter data that p65 
functions as an inhibitor of myogenesis. 
  The transcriptional activity of p65 derives from three TAs 
located in its C terminus (  Schmitz et al., 1994  ). To determine 
whether the regulation of myogenesis was dependent on p65 
transcriptional activity, reporter assays were repeated in   p65 
   /      
MEFs reconstituted with either p65 wild type (1  –  551 amino 
acids) or mutants truncated in TA1 (1  –  521) or all three (1  –  313) 
TA domains. Compared with vector, the addition of wild-type 
  Figure 1.       Loss of p65 enhances myogenic activity in MEFs.   (A)   p65 
+/+     and   p65 
    /        MEFs were cotransfected with cytomegalovirus-MyoD and either of the 
following reporter constructs: TnI-luc, AchR-luc, or 4RTK-luc. The next day, cells were switched to differentiation medium (DM), and, after 48 h, lysates were 
prepared and assayed for luciferase activity. (B)   p65 
+/+    ,   p65 
+/       ,   p65 
    /        and   pRb 
+/+    , and   pRb 
    /        primary MEFs were transfected with MyoD and TnI-luc. 
Cells were differentiated as in A, and luciferase assays were performed. (C)   p65 
    /       ,   cRel 
    /       , and   p50 
    /        MEFs were transfected with MyoD and TnI-luc, 
differentiated, and monitored for luciferase activity. (D) Myogenic assays similar to those described in A  –  C were performed in   I    B     
+/        and   I    B     
    /        cells. 
(inset) Electrophoretic mobility shift assay analysis of   I    B     
+/        and   I    B     
    /        MEFs. Error bars represent SEM.     JCB • VOLUME 180 • NUMBER 4 • 2008  790 
TNF      (  Doi et al., 1999  ). Thus,   TNF    
   /   ;p65 
+/        mice were 
crossed, and primary myoblasts were prepared from 2  –  4-d-old 
neonates (  Fig. 3 A  ). Transfections with TnI or MyHCIIB report-
ers showed that myogenic activity was substantially elevated in 
  p65 
   /       myoblasts, and, as in primary MEFs, this regulation ap-
peared to be gene dosage dependent (  Fig. 3 B  ). In comparison, 
  Myogenesis is accelerated in p65-deﬁ  cient 
myoblasts 
  To determine the physiological relevance of our fi  ndings, myo-
genesis was further explored in   p65 
   /       myoblasts.  Although 
mice lacking p65 are embryonically lethal (  Beg et al., 1995b  ), 
this phenotype can be rescued with the additional deletion of 
  Figure 2.       Loss of p65 accelerates the myogenic program in MEFs.   (A)   p65 
+/+     and   p65 
    /        MEFs were infected with MSCV-MyoD and, after puromycin 
selection, were sorted for GFP to ensure equal MyoD levels. Cells were then probed for p65 and MyoD (45 kD) protein.      -Tubulin (55 kD) was used as a 
loading control. (B)   p65 
+/+     and   p65 
    /        MEFs stably expressing MyoD were differentiated, and lysates were then probed for the indicated myogenic differ-
entiation markers. (C) Cells were differentiated as in B, and MyHC immunoﬂ  uorescence was performed. (D)   p65 
    /        MEFs were transfected with TnI-luc and 
either vector plasmid, wild-type p65 (1  –  551), or p65 TA mutants (1  –  521 and 1  –  313) along with MyoD. Cells were then differentiated, and lysates were 
prepared for luciferase assays. RLU, relative light units. (E)   p65 
    /        MEFs were reconstituted with either vector and full-length or truncated p65 along with 
MSCV-MyoD. After selection, whole cell lysates were prepared and probed for p65, MyoD, and      -tubulin. (F) Cells were infected as in E, differentiated for 
72 h, ﬁ  xed, and stained for MyHC. (G)   p65 
    /        MEFs were transfected with MyoD, TnI-luc, and either vector control, wild-type p65 (WT), or p65 constructs 
containing S/A mutation at positions 276, 529, and 536. MEFs were differentiated and harvested after 48 h for luciferase assays. (H) Relative luciferase 
activities from   p65 
    /        MEFs transfected with MyoD, TnI-luc, and either vector control, wild-type p65, or p65 (1  –  313) containing the S276A mutation. Error 
bars represent SEM. Bars: (C) 200      m; (F) 80      m.     791  IKK/NF-     B SIGNALING SWITCH IN SKELETAL MYOGENESIS   •   BAKKAR ET AL.
fi  brillar genes are silent in myoblasts, this suggested that p65 
functions as a transcriptional repressor of Tn, which is consis-
tent with our recent report that NF-     B is capable of silencing Tn 
enhancers through the production of YY1 and recruitment of 
Ezh2 and HDAC-1 (  Wang et al., 2007  ). Because TNF      has  re-
cently been shown to be required for muscle regeneration (  Chen 
et al., 2007  ), admittedly it was possible that the increase in 
muscle differentiation in   p65 
   /       myoblasts occurred secondary to 
myogenic activity in   p50 
   /       myoblasts was not signifi  cantly 
different from wild-type cells. Furthermore, under differentia-
tion conditions,   p65 
   /       myoblasts formed 58% more myotubes 
(  Fig. 3, C and D  ) and expressed higher levels of myofi  brillar 
proteins (  Fig. 3 E  ) compared with   p65 
+/+     cells. It is also note-
worthy that the modest but reproducible expression of Tn was 
detectable in   p65 
   /       myoblasts even under growth conditions 
(growth medium [GM];   Fig. 3 E  , asterisk). Given that myo-
  Figure 3.       Loss of p65 enhances the differentiation of primary myoblasts.   (A) Primary myoblasts were prepared from 2  –  4-d-old   TNF     
    /     ;p65 
+/+    , 
  TNF     
    /     ;p65 
+/       , and   TNF     
    /     ;p65 
    /        neonates, and genotypes were veriﬁ  ed by Western blots for p65. (B) p65 and p50 primary myoblasts were 
transfected with TnI-luc or MyHC-luc plasmids, differentiated for 48 h, and subsequently harvested for luciferase assays. RLU, relative light units. 
(C)   TNF     
    /     ;p65 
+/+     and   TNF     
    /     ;p65 
    /        myoblasts were differentiated for 0 h (GM) or 48 h (DM) and subsequently stained for MyHC. (D) Quantiﬁ  cation 
of myogenesis was performed by scoring MyHC-positive cells from a minimum of 25 ﬁ  elds normalized to total cell number as determined by Hoechst staining. 
(E) Myoblasts were differentiated for 0 (GM) and 48 h (DM), and lysates were probed for MyHC and Tn. The asterisk indicates Tn expression under 
GM conditions. (F) Primary or C2C12 myoblasts were transfected with siControl (siCont) or siRNA against p65 (sip65) along with Tn-luc reporter. Cells 
were switched to DM, and luciferase assays were performed. (G) C2C12 myoblasts were transfected with siControl or siRNA against p65 and switched 
to DM for 48 h, after which lysates were prepared and Western blots were performed. Error bars represent SEM. Bar, 80      m.     JCB • VOLUME 180 • NUMBER 4 • 2008  792 
fi  bers that were noticeably smaller in size than their wild-type 
counterpart (  Fig. 4 A  ). In p65-defi  cient tibialis anterior muscles 
from 4-wk-old male or female mice, mean fi  ber diameter was 
reduced by 39% as compared with wild-type littermates (25.6     m 
for wild type vs. 15.5      m for null;   n   = 5;   Fig. 4 B  ). This pheno-
type was common to multiple hind limb muscles and was se-
lective to p65 because no such differences were observed in 
  p50 
   /       mice (  Fig. 4 A  ). Slow MyHC staining from gastroc-
nemius muscles confi  rmed that the absence of p65 did not af-
fect fi  ber type (Fig. S1 A, available at http://www.jcb.org/cgi/
content/full/jcb.200707179/DC1). Although muscle atrophy is 
the loss of this cytokine. However, siRNA knockdown of p65 in 
primary myoblasts and C2C12 cells again led to increases in 
myogenic activity and muscle markers (  Fig. 3, F and G  ), sup-
porting results that negative regulation of myogenesis is specifi  c 
to p65 and is unlikely to be related to the absence of TNF    . 
  The absence of p65 enhances myogenesis 
in vivo 
  Next, we explored muscles from   TNF    
   /   ;p65 
   /       mice in an at-
tempt to correlate our in vitro fi  ndings with an in vivo phenotype. 
To our surprise, p65-null muscles displayed a large number of 
  Figure 4.       Myogenesis is enhanced in p65-deﬁ  cient mice.   (A) Hematoxylin- and eosin-stained cryosections of tibialis anterior (TA), gastrocnemius (Gastroc), 
and quadriceps (Quad) muscles from   TNF     
    /     ;p65 
+/+     and   TNF     
    /     ;p65 
    /        mice or   p50 
+/+     and   p50 
    /        gastrocnemius. (B) Fiber diameters were mea-
sured from gastrocnemius muscle sections from a total of 1,500 ﬁ  bers (  n   = 5 mice per group). (C) Fiber numbers were determined in whole cross sections 
from tibialis anterior muscles from   TNF     
    /     ;p65 
+/+     and   TNF     
    /     ;p65 
    /        mice (  n   = 3). (D) Fiber numbers were recorded from premeasured randomly 
selected areas (minimum of 25 per animal) throughout the tibialis anterior, gastrocnemius, and quadriceps muscles (  n   = 5 mice per genotype). Error bars 
represent SEM. Bar, 50      m.     793  IKK/NF-     B SIGNALING SWITCH IN SKELETAL MYOGENESIS   •   BAKKAR ET AL.
7 and 9 neonates (Fig. S1, C and D). These fi  ndings are consis-
tent with cell culture data suggesting that p65 absence in vivo 
leads to enhanced myogenesis, a phenotype highly reminiscent 
of dystrophin-defi  cient or acutely injured muscles depleted of 
p65 (  Acharyya et al., 2007  ). 
  p65 regulates myogenesis through multiple 
mechanisms 
  Next, we sought to address the mechanism by which p65 nega-
tively regulates myogenesis. Previous use of the I    B   -SR  in-
hibitor revealed that p65 can inhibit C2C12 differentiation 
through the suppression of MyoD synthesis (  Guttridge et al., 
2000  ). Such analysis also revealed that NF-     B is capable of in-
hibiting myogenesis through cyclin D1 (  Guttridge et al., 1999  ), 
an underlying cause of fi  ber reduction associated with induction 
of the E3 ubiquitin ligases MuRF1 and atrogene-1/MAFbx, 
muscles depleted for p65 displayed no evidence of this regula-
tion (Fig. S1 B). However, given our fi  ndings with primary myo-
blasts lacking p65, we considered the possibility that changes in 
  p65 
   /      muscles might result from an increase in overall myotube 
number. Indeed, fi  ber counts from entire cross sections of tibi-
alis muscles revealed a 76% increase in   p65 
   /       mice compared 
with control littermates (  Fig. 4 C  ). Similar results were found 
when counts were extended to gastrocnemius and quadriceps, 
demonstrating that this regulation is not muscle type specifi  c 
(  n   = 5;   Fig. 4 D  ). In addition, the   p65 
   /       phenotype was not re-
lated to a compromised immune function in adult mice because 
increases in fi  ber number were also observed in postnatal day (P) 
  Figure 5.       p65 regulation of myogenesis occurs through multiple mechanisms.   (A) C2C12 myoblasts were transfected with control and p65 siRNA, and lysates 
were harvested for Western analysis. (B)   MyoD 
    /        myoblasts were transfected with TnI-luc along with either an empty vector (CMV-Vect) or a p65 expression 
plasmid (CMV-p65) or were transfected with vector and subsequently treated with 5 ng/ml TNF     . Cells were differentiated for 2 d, and luciferase assays 
were performed. RLU, relative light units. (inset) Western blot for MyoD wild-type and null myoblasts. (C)   MyoD 
    /        myoblasts were infected with pBabe-Puro or 
pBabe-p65 retroviruses. After selection and differentiation for 3 and 5 d, protein lysates were prepared for Western analysis. (D)   MyoD 
    /        myoblasts stably 
expressing pBabe-Puro and pBabe-p65 were differentiated, ﬁ  xed, and stained for MyHC (red) and nuclei (Hoechst; blue). (E)   p65 
+/+     and   p65 
    /        MEFs were 
transfected with TnI-luc and either MyoD or myogenin plasmids. As a control, transfections were also performed with a p53 expression plasmid and responsive 
reporter (pGL13-luc). Cells were subsequently differentiated, and luciferase assays were performed. Error bars represent SEM. Bar, 80      m.     JCB • VOLUME 180 • NUMBER 4 • 2008  794 
(  Fig. 6 E  ), a time when cell fusion and contractile myofi  brillar 
expression is well underway. This activity was specifi  c to IKK 
because phosphorylation was undetectable when assays were re-
peated with a mutated substrate, and the increase in activity was 
not a consequence of altered protein expression because IKK 
subunits remained unchanged during myogenesis (  Fig. 6 E  ). 
  Next, we analyzed endogenous IKK substrates to ascer-
tain which IKK complex became activated during late stage 
myogenesis. As part of the classical pathway, IKK      activation 
results in the phosphorylation of I    B     and p65 (  Hayden and 
Ghosh, 2004  ). On the other hand, IKK      predominantly  phos-
phorylates p100, leading to its proteolysis and conversion to 
p52. Results revealed that levels of phosphorylated I    B     and 
p65 decreased during C2C12 differentiation, whereas total pro-
tein levels remained unchanged (  Fig. 6 F  ). Consistent with this 
decrease, nuclear p65 levels declined, and, by chromatin immuno-
precipitation (ChIP), p65 binding activity on the I    B     pro-
moter was also lost (  Fig. 6 F  ). In comparison, the processing of 
p100 to p52 was induced during myogenesis, with similar kinetics 
to C2C12 as well as primary myoblast differentiation (  Fig. 6 G   
and not depicted). Because IKK      activation results in the for-
mation of RelB  –  p52, we also investigated the contribution of 
these NF-     B subunits by repeating myogenic assays in   RelB 
   /      
and   p52 
   /       MEFs. Consistent with fi  ndings in   IKK    
   /       MEFs, 
myogenic activities were reduced in both   p52 
   /       and   RelB 
   /      
fi  broblasts (  Fig. 6 H  ). Together, these data suggest that skeletal 
myogenesis is characterized by a temporal switch in NF-    B  sig-
naling pathways whereby the reduction of classical NF-    B  is 
followed by activation of the alternative pathway relatively late 
in the myogenic program. 
  IKK     functions as a regulator of myotube 
maintenance under metabolic stress 
  The aforementioned data suggested that components of the alter-
native pathway might function to promote myogenesis. How-
ever, stable expression of an HA-tagged version of IKK      in 
C2C12 myoblasts did not affect induction of the early and late 
myogenic markers myogenin and Tn, respectively (  Fig. 7 A  ), nor 
was myogenic activity affected when IKK      or a kinase-dead 
version (K/M) of this kinase was overexpressed in MyoD-
  expressing 10T1/2 fi  broblasts (Fig. S3 A, available at http://www
.jcb.org/cgi/content/full/jcb.200707179/DC1). In comparison, 
the expression of classical signaling components IKK    ,  IKK   , 
or p65 led to clear reductions in myogenic activity in these same 
cells. Furthermore, no differences in skeletal muscle gene expres-
sion were detected by Affymetrix microarray between control 
and HA-IKK       –  expressing C2C12 myotubes (not depicted), and 
siRNA-mediated depletion of IKK      from differentiating myo-
blasts also revealed little change in myogenic markers (  Fig. 7 B  ). 
Therefore, although results from   IKK    
   /     ,   RelB 
   /      , and   p52 
   /      
MEFs suggested that the alternative pathway is promyogenic, over-
all, the data do not support that activation of this NF-    B  signaling 
pathway is necessary for myotube formation (see Discussion). 
  However, under long-term differentiation conditions (6 d) 
without medium replenishment, we observed that myotubes ex-
pressing HA-IKK      were better maintained compared with con-
trol cells (  Fig. 7 C  ). Specifi  cally, IKK    -expressing  myotubes 
limiting myoblasts from exiting the cell cycle or through YY1 
to silence myofi  brillar promoters in myoblasts (  Wang et al., 
2007  ). Consistent with these fi  ndings, MyoD was elevated in 
  p65 
   /       myoblasts, whereas both YY1 and cyclin D1 levels de-
clined (  Fig. 5 A  ). Thus, it is likely that p65 negatively regulates 
myogenesis through multiple mechanisms. 
  To determine whether these mechanisms could function 
independently of each other, we examined the regulation of 
myogenesis by p65 in   MyoD 
   /       myoblasts.  Although  myotube 
formation is impaired in these cells (  Sabourin et al., 1999  ), 
myogenic activity was nevertheless retained under differen-
tiation conditions (  Fig. 5 B  ). However, the addition of p65 or 
TNF      strongly repressed this activity. Likewise, retroviral ex-
pression of p65 in   MyoD 
   /       myoblasts caused a noticeable 
  reduction of myogenic markers (  Fig. 5  , C and D), demonstrat-
ing that p65 can inhibit myogenesis independently of MyoD. 
To substantiate this fi  nding, reporter assays were repeated in 
  p65 
+/+     and   p65 
   /       MEFs where MyoD was substituted with 
myogenin. Like MyoD, myogenin is capable of converting fi  bro-
blasts to a muscle lineage, albeit with lower effi  ciency (  Gerber 
et al., 1997  ). Indeed, myogenin-induced myogenic activity was less 
than that for MyoD, but these levels were nonetheless greater in 
  p65 
   /       MEFs compared with wild-type cells (  Fig. 5 E  ). This 
regulation also appeared specifi  c to these muscle regulatory fac-
tor proteins because a p53-responsive reporter was not affected 
by the absence of p65. 
  Myogenesis is regulated by a temporal 
switch in IKK signaling pathways 
  Having gained insight into the role of p65 in muscle differentia-
tion, we now turned our attention to its upstream regulator, the 
IKK complex. Recently, our group elucidated that chronic acti-
vation of IKK      in   mdx   muscles inhibits muscle differentiation 
(  Acharyya et al., 2007  ). Interestingly,   Mourkioti et al. (2006)   
have also reported that skeletal muscle deletion of IKK      in-
creased intermediate fi  ber numbers in 4-mo-old mice, a pheno-
type that closely matched that of younger   p65 
   /       mice (  Fig. 4  ). 
Such results suggested that p65 and IKK      share  overlapping 
functions in skeletal muscle differentiation. Indeed, analogously 
to p65, myogenic activity was increased in primary fi  broblasts 
and myoblasts deleted for IKK      fl oxed (f/f) alleles using Cre 
recombinase ( Fig. 6 A  and Fig. S2, A and B; available at http://www
.jcb.org/cgi/content/full/jcb.200707179/DC1). Likewise, 4-wk-
old mice lacking skeletal muscle IKK      exhibited an increase in 
total fi  ber number (  Fig. 6, B and C  ), reaffi  rming that IKK    ,  like 
p65, functions as a negative regulator of myogenesis. Because 
IKK      and p65 are components of classical NF-    B  signaling, 
myogenesis was also tested in   IKK    
   /       MEFs to address 
whether this pathway acts as a general inhibitor of differentia-
tion. Consistent with this thinking, myogenic activity was in-
creased in   IKK    
   /       MEFs but decreased in MEFs lacking 
IKK     , the latter of which is not considered part of the classical 
pathway (  Fig. 6 D    ; Senftleben et al., 2001  ). 
  To further explore the myogenic functions of IKK, we 
measured its activity in differentiating myoblasts. Results 
showed that IKK activation was relatively low in undifferenti-
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  expressing myotubes were also more resistant to low glucose 
but not to heat shock, oxidative stress, or DNA damage (  Fig. 7 C   
and not depicted), suggesting a selective resistance to metabolic 
were 48% less atrophic (26.0   ±   5.7     m  in  fi  ber diameter com-
pared with 13.5   ±   3.5      m in control cells) and overall exhibited 
a healthier morphological appearance. In addition, IKK    -
  Figure 6.       IKK signaling is temporally regulated and functionally distinct in myogenesis.   (A) IKK      (f/f) MEFs or myoblasts prepared from E13.5 embryos 
or 3-d-old pups, respectively, were infected with pBabe-Puro or pBabe-Cre retrovirus. After selection, cells were transfected with MyoD and TnI-luc, and 
luciferase assays were performed after 2 d in DM. (B) Hematoxylin- and eosin-stained cryosections from tibialis anterior muscles of 4  –  6-wk-old IKK      f/f and 
IKK      f/f;muscle creatine kinase  –  Cre mice. (C) Fiber numbers were determined from premeasured randomly selected areas (minimum of 25 per animal) 
throughout the tibialis anterior muscle (  n   = 3 mice per genotype). *, P = 0.005. (D) IKK wild-type and null MEFs were transiently transfected with MyoD and 
TnI-luc, and, after 2 d in DM, lysates were prepared for luciferase assays. (E) C2C12 myoblasts were differentiated, and, at the indicated times, cells were 
harvested, and lysates were prepared for IKK kinase assays using wild-type or serine to alanine mutant I     B      proteins as substrates (KA, kinase assay; WB, 
Western blot). (F) C2C12 cells were differentiated, and, at the indicated time points, extracts were prepared to probe for phosphorylated I     B     , total I     B     , 
phosphorylated p65, and total p65. Parallel samples were prepared for nuclear extraction, and Western blots were performed for nuclear p65. Parallel 
differentiated C2C12 cells were immunoprecipitated with a p65 antibody and processed for chromatin immunoprecipitation (ChIP). Fragments from the 
I     B      promoter were ampliﬁ  ed by PCR before (input) or after immunoprecipitation. (G) Lysates from differentiating C2C12 cells were prepared and used 
to probe for p100  –  p52 and      -tubulin. (H) MEFs wild type or null for p52 and RelB were transfected with MyoD and TnI-luc. Cells were differentiated for 
48 h and prepared for luciferase assays. Error bars represent SEM. Bar, 0.5      m.     JCB • VOLUME 180 • NUMBER 4 • 2008  796 
  alternative pathway during myogenesis functions to maintain 
myotubes in response to metabolic stress. 
  IKK     regulates mitochondrial biogenesis 
  Finally, we attempted to address the process by which IKK     
controls myotube maintenance. Because IKK      regulation  ap-
peared selectively linked to starvation stress, we speculated that 
this kinase was involved in regulating the energy capacity of dif-
ferentiating muscle. Energy production during myogenesis occurs 
through a switch from glycosidic to oxidative phosphorylation 
stress. This effect was dependent on the kinase activity of IKK     
because myotube maintenance was lost upon expression of a 
kinase-dead mutant (  Fig. 7 D  ). Moreover, siRNA deletion of the 
      but not the       subunit of IKK negated this protective effect 
upon glucose deprivation, confi  rming the specifi  city of IKK      in 
this regulation (  Fig. 7 E  ). Furthermore, 6-d starved IKK    -
  expressing myotubes displayed higher levels of the myogenic 
markers myogenin, Tn, MyHC, and activated p38, whereas 
these markers were reduced upon IKK      knockdown (  Fig. 7 F  ). 
Together, these data suggest that activation of IKK      and the 
  Figure 7.       IKK     regulates myotube maintenance.   (A) C2C12 cells were transfected with vector or HA-IKK      expression plasmids. After selection, cells 
were differentiated and harvested for Western analysis probing for HA and myogenic markers. (B) Myoblasts were transfected with siControl or siIKK      
oligonucleotides and differentiated, and Western blotting was performed as in A. (C) 3-d differentiated myotubes stably expressing vector or IKK      were 
subjected to varying stress conditions, including no media replenishment for 6 d (6 d in DM) or low glucose (1 g/L glucose in DM for 48 h). Cells were 
then ﬁ  xed and photographed by phase contrast at 20  ×   magniﬁ  cation. (D) Differentiated myotubes stably expressing wild-type (WT) or a kinase-dead (KD) 
version of IKK      were switched to low glucose for 24 h and photographed by phase contrast. (E) Myotubes expressing siControl, siIKK     , or siIKK      were 
differentiated for 3 d and switched to low glucose for 20 h before ﬁ  xation. Parallel samples were harvested for Western blots to conﬁ  rm knockdown ef-
ﬁ  ciency. (F) C2C12 cells expressing vector or IKK      were differentiated for 6 d. Lysates were subsequently prepared for Western blots probing for IKK      and 
myogenic markers. Bars, 200      m.     797  IKK/NF-     B SIGNALING SWITCH IN SKELETAL MYOGENESIS   •   BAKKAR ET AL.
ferentiating myoblasts also revealed signifi  cantly higher levels 
of MTCO1 DNA compared with vector cells, whereas the depletion 
of IKK      led to a reduction of MTCO1 (  Fig. 8 B  ). This sug-
gested the possible novel fi  nding that IKK      is a regulator of 
mitochondrial biogenesis. Consistent with this notion, myotubes 
resulting from an increase in mitochondrial content (  Moyes et al., 
1997; Lyons et al., 2004  ). Using semiquantitative PCR and the 
mitochondrial marker gene cytochrome oxidase 1 (MTCO1), 
we readily detected an increase in mitochondrial DNA during 
C2C12 myogenesis (  Fig. 8 A  ). Examination of HA-IKK      dif-
  Figure 8.       IKK     regulates mitochondrial biogenesis.   (A) DNA was prepared from GM or 3-d DM C2C12 cells, diluted, and used to amplify a 648-bp 
fragment from MTCO1. Separate PCR for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used to normalize for loading. (B) C2C12 cells stably 
expressing vector (Vect) or IKK      were differentiated, and DNA samples were prepared for the determination of mitochondrial number as in A. (C) Vec-
tor and IKK     -overexpressing cells were differentiated for 3 d and stained for mitochondria with MitoTracker green. Staining was viewed by ﬂ  uorescence 
at 20  ×   magniﬁ  cation. (D) Mitochondrial and cytoplasmic extracts were prepared from HA-IKK      or IKK     -depleted myotubes, and lysates were probed 
for cytochrome   c  . (E) IKK     -expressing or -depleted cells were differentiated for 3 d and lysed, and ATP production was measured by luminescence. 
An ATP standard curve was generated in parallel to convert luminescence readings into [ATP] (*, P = 0.02; **, P = 0.001). (F) Vector and IKK      cells were 
differentiated, lysed, and prepared for a citrate synthase assay. All experiments were initiated with equal protein and were performed during the linear 
phase of the reaction to ensure adequate substrate amounts (*, P = 0.01). A parallel set of myotubes expressing vector or IKK      was cultured and switched 
to DM, and dehydrogenase activity was measured by the conversion of MTS tetrazolium into aqueous formazan. Readings were taken at 15 min before 
saturation (**, P = 0.001). (G) C2C12 cells were transfected with vector, p52  –  RelB, or p50  –  p65 and differentiated for 3 d. DNA was prepared for the 
determination of mitochondrial numbers as in A or was processed for the determination of ATP production as in E (*, P = 0.001; **, P = 0.03). Error bars 
represent SEM. Bar, 40      m.     JCB • VOLUME 180 • NUMBER 4 • 2008  798 
chondria is linked to myotube maintenance, we treated C2C12 
myotubes with mitochondrial inhibitors chloramphenicol and 
oligomycin under glucose deprivation. This led to visibly less 
numbers of preserved myotubes (Fig. S3 B), a phenotype strik-
ingly similar to IKK     -depleted cells. Collectively, our results 
strongly support that activation of NF-     B alternative signaling 
during myogenesis does not function to promote myotube for-
mation but rather is important for regulating mitochondrial bio-
genesis and myotube homeostasis. 
  Discussion 
  Recent studies have shown that chronic activation of NF-    B  is 
detrimental to muscle function. In skeletal muscles, NF-    B  has 
been linked with disease states such as cachexia and various 
forms of muscular dystrophies and infl  ammatory myopathies 
( Baghdiguian et al., 1999 ;  Kumar and Boriek, 2003 ;  Monici et al., 
2003; Hunter and Kandarian, 2004  ;   Acharyya et al., 2007  ). 
Although such studies implicate NF-     B as a therapeutic target, 
mechanistically, relatively little is known about how this tran-
scription factor mediates its pathological effects. Elucidation 
of these mechanisms might be better achieved by studying 
NF-     B function in basic models of skeletal myogenesis. How-
ever, even in tissue culture systems, reports have confl  icted as to 
whether NF-     B acts as a repressor or promoter of myogenesis 
( Lehtinen et al., 1996 ;  Guttridge et al., 1999 ;  Kaliman et al., 1999 ; 
  Canicio et al., 2001  ;   Langen et al., 2001  ;   Conejo et al., 2002  ; 
  Munz et al., 2002  ;   Baeza-Raja and Munoz-Canoves, 2004  ). 
In the present study, we describe what we believe to be a new 
  understanding for the role of NF-     B in skeletal muscle differ-
entiation. Our fi  ndings reveal that NF-     B is capable of func-
tioning as both a repressor of differentiation and a promoter of 
overexpressing IKK      contained higher levels of the mitochon-
drial dye MitoTracker (  Fig. 8 C  ). In addition, mitochondrial 
fractions from these cells were also enriched in cytochrome   c , 
which were, in turn, reduced upon the expression of IKK     
siRNA (  Fig. 8 D  ). Furthermore, total ATP was elevated by 72% 
in IKK   -expressing myotubes (P = 0.001), whereas IKK    knock-
down caused an 18% reduction in ATP levels (P = 0.02;  Fig. 8 E ). 
To address whether the increase in mitochondrial content by 
IKK     refl  ected mitochondrial function, biochemical assays were 
performed for citrate synthase and dehydrogenase enzymes. 
  Results showed that enzyme activities were signifi  cantly increased 
in IKK     -expressing myotubes (  Fig. 8 F  ). This function appeared 
selective to the NF-     B alternative pathway because p52  –  RelB 
but not p50  –  p65 increased MTCO1 and ATP (  Fig. 8 G  ). Further-
more, ATP levels were also increased in MEF and HeLa cells 
overexpressing IKK      (unpublished data), suggesting that IKK     
regulation of mitochondria is not specifi  c to skeletal muscle. 
  To further investigate this regulation, ultrastructural anal-
ysis was performed in IKK      overexpression and knockdown 
conditions. Remarkably, HA-IKK     – expressing  myotubes  dis-
played elongated networks of mitochondria, a hallmark of ex-
tensive proliferation (  Fig. 9 A  ). Conversely, IKK      knockdown 
resulted in degenerating organelles, which was indicated by 
swelling and the absence of cisternae in the mitochondrial ma-
trix (  Fig. 9 B  ). In addition, genome-wide L2L analysis (  Newman 
and Weiner, 2005  ) of microarray data from IKK      mytotubes 
identifi  ed 126 selectively enriched biological processes in genes 
that were up-regulated (  >  1.5-fold). From these, 48% were in-
volved in mitochondrial and metabolic regulation (  Fig. 9 C  ), 
whereas signifi  cantly fewer IKK      regulated genes associated 
with transcription/translation (12%) or even skeletal myogenic 
processes (6%). To examine whether the regulation of mito-
  Figure 9.       IKK     controls mitochondrial structure.   (A) Ultrathin sections from vector or IKK     -expressing myotubes were analyzed by EM at 18,500  ×   direct 
magniﬁ  cation. (B) Myotubes expressing control or IKK      siRNA were sectioned and visualized by EM as in A. (C) Microarray analysis was performed on 
vector and IKK     -expressing myotubes using the murine MG430.20 Affymetrix chip. Genes up-regulated in IKK      myotubes as compared with vector were 
analyzed by L2L analysis (http://depts.washington.edu/l2l/) for statistically signiﬁ  cant enriched biological processes. Bars, 500 nm.     799  IKK/NF-     B SIGNALING SWITCH IN SKELETAL MYOGENESIS   •   BAKKAR ET AL.
in skin differentiation (  Hu et al., 2001  ;   Sil et al., 2004  ) or 
NF-    B – dependent gene expression ( Anest et al., 2003 ;   Yamamoto 
et al., 2003; Hoberg et al., 2004  ), we were unable to detect 
 nuclear  IKK     in myoblasts or myotubes (unpublished data). 
  Although our current results do not rule out the possibility that 
IKK      might still phosphorylate an unknown target to modulate 
myogenic gene expression, we favor instead that IKK      function 
in skeletal muscle differentiation is represented by the alterna-
tive pathway requiring the cytoplasmic form of IKK      to acti-
vate p52  –  RelB complexes. 
  Evidence from   IKK    
   /     ,   p52 
   /      , and   RelB 
   /       MEFs indi-
cated that alternative activation of NF-     B is required for myo-
genic activity. These results appear consistent with previous 
fi  ndings implicating IKK      as a positive regulator of myogene-
sis (  Canicio et al., 2001  ). However, in contrast to these fi  ndings, 
we were unable to demonstrate by either forced expression or 
RNAi depletion that IKK      is essential for the induction of myo-
genic genes or myotube formation. Although genetic evidence 
from p65 and IKK      knockout MEFs was consistent with how 
these classical signaling components were found to function in 
muscle cells, we do not yet understand why this same consis-
tency was not present between   IKK    
   /       MEFs and C2C12 cells 
depleted of IKK      with siRNA. Possibly, the fraction of IKK     
that remains in cells after siRNA depletion is suffi  cient to mask 
a phenotype that otherwise requires its complete absence, or 
perhaps the increase in myogenic activity derived from estab-
lished   IKK    
   /       MEFs might be an indirect consequence of 
  immortalization and continued subculturing. We suspect that 
additional myogenic reporter assays in primary   IKK    
   /       MEFs 
and myoblasts will be needed to clarify this issue. 
  Nevertheless, our observations led to the novel discovery 
that IKK      acts as a regulator of mitochondrial biogenesis. 
Although the mechanism remains unknown, we predict that IKK    
activation functions through p52  –  RelB to promote mitochondrial 
biogenesis and meet the metabolic needs of newly formed con-
tractile myotubes. The inhibitor compounds of mitochondria were 
also seen to decrease myotube maintenance, suggesting that IKK    
regulation of mitochondria is necessary for myotube homeostasis 
in response to changing metabolic conditions. 
  A model for IKK/NF-    B signaling in skeletal 
muscle differentiation 
  Collectively, our data support a model whereby IKK/NF-    B 
signaling both inhibits and promotes the differentiation state of 
muscle cells (  Fig. 10  ). This model helps unify the literature on 
the contradictory functions of NF-     B in myogenesis and pre-
dicts that during differentiation, a temporal switch occurs be-
tween NF-     B classical and alternative signaling pathways. 
In myoblasts, classical signaling is constitutively active and func-
tions to maintain cells in an undifferentiated state. This function 
is regulated through the control of MyoD as well as other 
MyoD-independent mechanisms involving cyclin D1 and YY1. 
Once differentiation cues are initiated, classical signaling is 
turned down, whereas the alternative pathway is induced late in 
the myogenic program. In turn, the activation of IKK      leading 
to p52  –  RelB association regulates myogenesis by mediating the 
production of mitochondria necessary to satisfy the metabolic 
myotube maintenance depending on specifi  c activities of IKK 
and NF-    B  subunits. 
  p65 and the classical NF-    B signaling 
pathway function as negative regulators 
of myogenesis 
  Utilization of knockout MEFs demonstrated that myogenic ac-
tivity was enhanced in cells lacking p65, and comparisons with 
all fi  ve NF-     B subunits showed that this activity was highest in 
  p65 
   /       cells. Therefore, although myoblast nuclei have been 
shown to contain constitutive activity for p50 and p65 (  Guttridge 
et al., 1999  ), our current data argue that suppression of myogen-
esis by NF-     B is mediated specifi  cally through p65. This notion 
is consistent with results in primary myoblasts in which myo-
genic activity was also elevated in p65- but not p50-null cells. 
Together, these genetic data reaffi  rm that p65 activity in prolif-
erating myoblasts functions as a negative regulator of myo-
genesis. This function of p65 is evident in muscle injury, in which 
the lack of p65 enhances myogenesis in   mdx   and toxin-treated 
mice (  Acharyya et al., 2007  ). Given that p65 defi  ciency corre-
lated with increases in overall fi  ber numbers in young and adult 
mice, it suggests that p65 is also relevant during postnatal mus-
cle growth, as indicated by the high levels of NF-     B activity in 
muscles from neonates (  Acharyya et al., 2007  ). Why p65 would 
function in this capacity at this stage of development is not yet 
known, and whether it functions in a similar manner during em-
bryonic or fetal myogenesis remains to be investigated. 
  Our current results demonstrate that regulation of myo-
genesis is dependent on p65 transcriptional activity. This notion 
is in line with our previous fi  ndings that NF-   B inhibits myogen-
esis through the transcriptional activation of cyclin D1 ( Guttridge 
et al., 1999  ). Repression of myogenesis by p65 has also been 
seen in response to TNF   , leading to the loss of MyoD ( Guttridge 
et al., 2000  ) and, more recently, to the gain of YY1, resulting in 
silencing of myofi  brillar genes (  Wang et al., 2007  ). Thus, p65 
requires its transactivation function to suppress muscle differ-
entiation, and results from   MyoD 
     /       myoblasts support that this 
can occur via multiple mechanisms. 
  Similar to p65, we discovered that myogenic activity was 
enhanced in MEFs lacking classical components IKK      and 
IKK     . Like p65, IKK      deletion in muscle led to increases in fi  -
ber number and to enhanced myogenesis, as recently reported 
in   mdx   mice (  Acharyya et al., 2007  ). Collectively, these data 
argue strongly that classical NF-     B signaling functions as a 
negative regulator of muscle differentiation in both physiological 
and disease processes. 
  IKK     signaling promotes myotube 
maintenance through mitochondrial 
biogenesis 
  With respect to alternative NF-     B signaling, our results showed 
that activation of IKK during myogenesis is selective to IKK    , 
as this activity tightly correlated with p100 processing. Such acti-
vation was preceded by a decline in classical pathway activity, 
which is depicted by decreases in I    B     and p65 phosphoryla-
tion, as well as p65 nuclear and DNA-bound levels. In contrast 
to recent fi  ndings that nuclear localization of IKK      is required JCB • VOLUME 180 • NUMBER 4 • 2008  800 
tein extraction reagent solution (Thermo Fisher Scientiﬁ  c), and assays were 
performed as previously reported (  Guttridge et al., 1999  ). IKK     , IKK     , 
and p65 siRNAs were obtained from Dharmacon, Inc., and transfections 
were performed using Lipofectamine 2000. Retrovirus production and in-
fection were performed as previously described (  Guttridge et al., 1999  ). 
  Mice and genotyping 
  Animals were housed in the animal facility at The Ohio State University 
Heart and Lung Research Institute under sterile conditions maintaining 
constant temperature and humidity and were fed a standard diet. Treat-
ment of mice was in accordance with the institutional guidelines of the 
Animal Care and Use Committee. Mice null for p65 were generated as 
previously described (  Doi et al., 1999  ). p50 mice were obtained from 
Jackson ImmunoResearch Laboratories, and IKK      ﬂ   ox mice (  Li et al., 
2003  ) were crossed to muscle creatine kinase  –  Cre mice to delete IKK      in 
skeletal muscle. Mice genotypes were conﬁ  rmed by PCR analysis from 
prepared tail DNA. 
  Cell culture 
  C2C12 murine myoblasts and ﬁ  broblasts were cultured as previously de-
scribed (  Guttridge et al., 2000  ). Primary myoblasts were prepared from 
2-d-old neonates adopted from the described procedures (  Rando and 
Blau, 1994  ). In brief, limbs from pups were skinned and incubated with 
collagenase/dispase mixture at 37  °  C for 1 h. Then, the cell suspension 
was further homogenized by pipetting and preplated on uncoated cell 
  culture plates in F10 media (Invitrogen) to selectively enrich for myoblasts. 
After two rounds of preplating, the cell suspension was plated on gelatin-
precoated plates in the presence of 20% FBS and 6 ng/ml basic FGF. 
  Primary myoblasts were used at passage 3  –  5 after isolation. 
  Immunoblotting, Northern blots, ChIP, and kinase assays 
  Western and Northern blots and kinase analyses were performed as de-
scribed previously (  Hertlein et al., 2005  ). For ChIP, assays were performed 
as recommended by the manufacturer (Millipore). 
  Histology, electron microscopy, and immunoﬂ  uorescence 
  For muscle analysis, tissues were sectioned at 10      m on a cryostat (Leica) 
and stained with hematoxylin and eosin or processed for immunohisto-
chemistry. The internal diameters (shortest diameter) from 1,200 ﬁ  bers in 
random ﬁ  elds throughout the muscle were recorded using a microscope 
(BX50; Olympus) and MetaVue 6.2r6 software (MDS Analytical Tech-
nologies). Fiber number was recorded in 25 randomly selected ﬁ  elds 
throughout the muscle and averaged for comparisons. Muscles from three 
to ﬁ   ve different animals per group were used. Immunostaining proce-
dures on cell lines and muscle sections were performed as described pre-
viously (  Acharyya et al., 2004, 2005  ), and all images were captured 
with a ﬂ  uorescent microscope (Axioskop 40; Carl Zeiss, Inc.) using a 
needs of contractile muscle cells. Although cooperative func-
tions of NF-     B signaling pathways are important for mam-
mary and osteoclast tissue development (  Demicco et al., 2005  ; 
 Ruocco et al., 2005 ), skeletal muscle is, to the best of our knowl-
edge, the fi  rst example of a differentiation system regulated 
through a functional switch of classical and alternative NF-    B 
signaling pathways. 
  Materials and methods 
  Materials 
  Antibodies to p100  –  p52, I     B      (C21), IKK     , IKK      (FL419), myogenin (M-225), 
p38, MyoD (M-318), and p65 (N terminal) were obtained from Santa 
Cruz Biotechnology, Inc. MyHCIIB (MY-32), MyHC slow (NOQ7.5.4D), 
Tn T (JLT-12), sarcomeric tropomyosin (CH1), and      -sarcomeric actin (5C5) 
were purchased from Sigma-Aldrich. p65 antibody was obtained from 
Rockland Immunochemicals, Inc., HA was purchased from Covance, and 
IKK      was purchased from Imgenex. Phospho-I     B     , p38, and p65 were 
obtained from Cell Signaling Technology, and cytochrome   c   was pur-
chased from BD Biosciences. Bovine insulin, collagen type I, and gelatin 
were obtained from Sigma-Aldrich, whereas TNF      was purchased from 
Roche. Both collagenase P and dispase (grade II) were obtained from 
Boehringer Mannheim. Basic human FGF was purchased from Promega, 
and oligomycin was obtained from Alexis Biochemicals. MitoTracker green 
and secondary antibodies for immunoﬂ  uorescence were obtained from 
Invitrogen, whereas other materials for immunohistochemical analysis were 
obtained from Vector Laboratories. 
  Plasmids 
  Reporter and p65 expression plasmids were previously described (  Guttridge 
et al., 1999  ;   Acharyya et al., 2004  ;   Hertlein et al., 2005  ) with the excep-
tion of the p65(1  –  313; S276A) mutant, which was generated by mutating 
serine 276 to alanine in the p65(1  –  313) plasmid. MSCV-MyoD was gener-
ated by subcloning the MyoD cDNA from a pBabepuroMyoD retroviral 
construct (  Guttridge et al., 2000  ). IKK plasmids were designed by subclon-
ing IKK     , IKK     , and IKK      into the pBSx-HSAvpA plasmid, whereby trans-
gene expression is driven from the human skeletal actin promoter. 
  Transfections, luciferase assays, and retrovirus infections 
  Subconﬂ  uent C2C12 cells were transfected in low serum Opti-MEM using 
Lipofectamine (Invitrogen) according to the manufacturer. For luciferase as-
says, cells were transiently transfected using Superfect (QIAGEN) for MEFs 
or Lipofectamine for primary myoblasts. All transfections were normalized 
to cytomegalovirus-     Gal expression. Cells were lysed in mammalian pro-
  Figure 10.       A model for IKK/NF-    B signaling and function in skeletal myogenesis.   The model depicts different phases of myogenesis from proliferating myo-
blasts to differentiated myotubes. In proliferating myoblasts, classical NF-     B signaling mediated by IKK      and IKK      leads to the activation of p65 that binds 
DNA and regulates gene expression to inhibit myogenesis. During differentiation, classical NF-     B is down-regulated, whereas the alternative signaling be-
comes activated. Activation of alternative signaling occurs late in the myogenic program to regulate mitochondrial biogenesis and myotube maintenance.     801  IKK/NF-     B SIGNALING SWITCH IN SKELETAL MYOGENESIS   •   BAKKAR ET AL.
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camera (AxioCam HRc; Carl Zeiss, Inc.) and AxioVision 3.1 software 
(Carl Zeiss, Inc.). Ultrastructural analysis was performed on ﬁ  xed cells 
and sectioned using a microtome (EM UC6; Leica) at 70 nm. Sections 
were then stained and visualized using a transmission electron micro-
scope (Spirit Tecnai; FEI) at 80 kV, and images were captured with a 
camera (XR60; Advanced Microscopy Techniques). 
  Mitochondrial assays 
  Both CellTiter-Glo Luminescent Assay for ATP determination and MTS cell 
viability assays were obtained from Promega and performed according to 
the manufacturer  ’  s recommendations. Citrate synthase activity was deter-
mined by using Ellman  ’  s reagent with acetyl-CoA and oxaloacetate (  Leek 
et al., 2001  ). Procedures for primer design and PCR of MTCO1 as well as 
mitochondrial extraction for identiﬁ  cation of cytochrome   c   were followed 
as described previously (  Huo and Scarpulla, 2001  ;   Liu et al., 2004  ). 
  Statistical analysis 
  All quantitative data are represented as means   ±   SEM. Analysis was per-
formed between different groups using a two-tailed   t   test. Statistical signiﬁ  -
cance was set at P   <   0.05. 
  Online supplemental material 
  Fig. S1 shows that the absence of p65 in young mice leads to increases 
in ﬁ   ber numbers that is independent of ﬁ   ber type and muscle atrophy. 
Fig. S2 shows evidence for the conditional deletion of IKK      in primary 
ﬁ   broblasts and adult muscles. Fig. S3 shows that the NF-     B classical 
pathway inhibits myogenesis in 10T1/2 ﬁ   broblasts, whereas C2C12 
myotubes are not maintained with compounds that inhibit mitochondria. 
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content/full/jcb.200707179/DC1. 
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